Does hereditary angioedema make COVID-19 worse?
Review article
[키워드] Abnormalities
ACE2
acute respiratory syndrome
aggravate
angiotensin-converting enzyme 2
Asymptomatic carrier
attack
cells
clinical trial
Comorbidity
complement
complement system
Contact
contact system
coronavirus
coronavirus disease
COVID-19
COVID-19 progression
cytokine release
deplete
Disease activity
favor
HAE
hematologic
Hereditary angioedema
host cell
Hypothesis
induce
Inflammation
inhibitor
Interaction
Lung injury
mechanism
medication
metabolism
mutations
outcomes
pandemic
Pathogenesis
pathophysiologic
Patient
performed
Prophylactic
Prophylaxis
receptor
risk
SARS-CoV-2
SARS-COV-2 infection
Spread
T helper
therapeutic strategy
Treatment
turn
[DOI] 10.1016/j.waojou.2020.100454 [Article Type] Review article
[DOI] 10.1016/j.waojou.2020.100454 [Article Type] Review article